Vertex Pharmaceuticals (VRTX): Westwood Holdings Group Inc added to its stake +71K shares
Westwood Holdings Group Inc added to its stake in Vertex Pharmaceuticals, per its Q1 2025 13F.
- 74K
- Shares reported · +71K vs prior quarter
- 0.27%
- Disclosed portfolio weight
- $35.9M
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- May 9, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 11, 2024Congress · 1 personMembers of Congress: 2 purchases
- Mar 10, 2025Insider · 3 peopleInsiders: 3 sales (~$4.9M)
- Mar 13, 2025InsiderOfficer sold ~$1.65M of VRTX shares in the open market
- Mar 13, 2025CongressDisclosed purchase of VRTX — reported range $15,001 - $50,000
- Mar 20, 2025Congress · 1 personMembers of Congress: 2 sales
- May 2, 2025InsiderDirector sold ~$202K of VRTX shares in the open market
What came next
- May 12, 2025CongressDisclosed sale of VRTX — reported range $15,001 - $50,000
- May 15, 2025InsiderOfficer sold ~$22K of VRTX shares in the open market
- May 22, 2025FDAFDA drug approval: Kalydeco
- May 22, 2025FDAFDA drug approval: Kalydeco
- Jun 10, 2025CongressDisclosed partial sale of VRTX — reported range $1,001 - $15,000
- Jun 11, 2025Congress · 1 personMembers of Congress: 2 sales
- Aug 6, 2025Insider · 2 peopleInsiders: 4 purchases (~$5.8M)
- Aug 7, 2025CongressDisclosed purchase of VRTX — reported range $1,001 - $15,000
- Aug 27, 2025InsiderDirector sold ~$103K of VRTX shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Vertex Pharmaceuticals
For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.
How this filing works
Explore the data
Common questions
What does this filing report about Vertex Pharmaceuticals (VRTX) stock?
Westwood Holdings Group Inc added to its stake in Vertex Pharmaceuticals, per its Q1 2025 13F. Now 74K shares, $35.9M reported value, 0.27% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: May 9, 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Vertex Pharmaceuticals recently?
For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the VRTX page.
Does this mean VRTX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Vertex Pharmaceuticals
- SEC Form 144Nov 16, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 10, 2026
Everything OQRO holds on this company is on its VRTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
